breakfast brief

Melanoma has long been at the cutting edge of immuno-oncology research, which will likely continue. The way for future headlines is already paved.

PD DDr. Sacha Rothschild from Universitätsspital Basel, reports about highlights, but also some disappointing news from day three of ESMO Congress 2018.

In this Breakfast Brief, PD DDr. Sacha Rothschild, Universitätsspital Basel, summarizes his personal highlights of the first two days of ESMO Congress 2018.

In this Breakfast Brief, PD Dr. Richard Cathomas, Kantonsspital Graubünden, Chur, presents his Immune-Oncology highlights of the first two days of ESMO Congress 2018.

Mag. Simone Peter-Ivkić interviewte Prof. Michielin über die Schwerpunkte des ESMO 2017 Kongresses zum Thema "Immuno-Oncology".

Prof. Prager spricht in diesem Video über seine Eindrücke der European Society for Medical Oncology 2017 (ESMO).

Wir interviewten Dr. Curioni auf der ESMO 2017 zu ihren Eindrücken der Veranstaltung und zu den neuesten Forschungsergebnissen.